Position in HLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,455,729
-$923,335 QoQ
Shares Held
370,389
-15.3% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
1.48%
of 13F equity value
Holder Rank
#87
of 639 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 20262Xideas AG holds $6,280,965 across 2 Drug Manufacturers - Specialty & Generic names. HLN ranks #1 (55.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
This page
|
370,389 | $3,455,729 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
16,763 | $2,825,236 |
All Filings in HLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,455,729 | 370,389 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,379,064 | 437,469 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||